EB
CAPR icon

Eastern Bank’s Capricor Therapeutics CAPR Stock Holding History

Eastern Bank’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$890 Buy
+94
New +$1.04K ﹤0.01% 1067

Other funds holding CAPR

GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Eastern Bank's CAPR Position: Q3 2026 in Review

Eastern Bank opened a new position in Capricor Therapeutics (CAPR) in Q3 2026: 94 shares worth $890. The stake represents ﹤0.01% of the portfolio and ranks #1067 among its holdings.

4 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Eastern Bank held 94 shares of Capricor Therapeutics worth $890 as of Q3 2026.
  • Capricor Therapeutics was a new Eastern Bank position in Q3 2026.
  • Capricor Therapeutics made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #1067 holding.
  • 4 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.